Nicole Cossrow

1.1k total citations
26 papers, 871 citations indexed

About

Nicole Cossrow is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Nicole Cossrow has authored 26 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 6 papers in Infectious Diseases and 4 papers in Health. Recurrent topics in Nicole Cossrow's work include Pneumonia and Respiratory Infections (11 papers), Vaccine Coverage and Hesitancy (4 papers) and Emergency and Acute Care Studies (3 papers). Nicole Cossrow is often cited by papers focused on Pneumonia and Respiratory Infections (11 papers), Vaccine Coverage and Hesitancy (4 papers) and Emergency and Acute Care Studies (3 papers). Nicole Cossrow collaborates with scholars based in United States, Netherlands and Germany. Nicole Cossrow's co-authors include Bonita Falkner, Ravi Potluri, Maneesha Mehra, Erik R. Dubberke, Manjiri Pawaskar, Eileen E. Ming, Timothy W. Victor, Edward A. Witt, Barry K. Herman and Thomas A. Wadden and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Nicole Cossrow

22 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole Cossrow United States 9 244 208 126 121 118 26 871
Anupama Kalsekar United States 18 119 0.5× 250 1.2× 104 0.8× 104 0.9× 58 0.5× 55 1.5k
Denise C. Vidot United States 21 279 1.1× 164 0.8× 370 2.9× 70 0.6× 209 1.8× 89 1.1k
Gregory Traversy Canada 10 305 1.3× 199 1.0× 74 0.6× 85 0.7× 135 1.1× 14 919
Giovanni Baglìo Italy 22 313 1.3× 120 0.6× 300 2.4× 96 0.8× 162 1.4× 111 1.4k
Sam Kosari Australia 20 90 0.4× 192 0.9× 97 0.8× 58 0.5× 117 1.0× 71 1.0k
Yelena Bird Canada 17 162 0.7× 223 1.1× 195 1.5× 44 0.4× 255 2.2× 32 1.0k
Ai‐Lin Tsai United States 20 252 1.0× 224 1.1× 49 0.4× 166 1.4× 67 0.6× 36 1.1k
Arlene Hankinson United States 15 360 1.5× 113 0.5× 109 0.9× 53 0.4× 295 2.5× 27 873
Caleb Bliss United States 14 105 0.4× 405 1.9× 122 1.0× 43 0.4× 61 0.5× 32 893
Roxane Carr Canada 17 219 0.9× 87 0.4× 163 1.3× 60 0.5× 38 0.3× 47 1.0k

Countries citing papers authored by Nicole Cossrow

Since Specialization
Citations

This map shows the geographic impact of Nicole Cossrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Cossrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Cossrow more than expected).

Fields of papers citing papers by Nicole Cossrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Cossrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Cossrow. The network helps show where Nicole Cossrow may publish in the future.

Co-authorship network of co-authors of Nicole Cossrow

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Cossrow. A scholar is included among the top collaborators of Nicole Cossrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Cossrow. Nicole Cossrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mohanty, Salini, Kelsie Cassell, Nicole Cossrow, et al.. (2025). Influence of area-level social vulnerability on all-cause pneumonia incidence among adult Medicare and Medicaid enrollees. Communications Medicine. 5(1). 467–467.
2.
Waskin, Hetty, et al.. (2025). Posaconazole effectiveness in rare invasive fungal infections: A systematic literature review. International Journal of Antimicrobial Agents. 66(1). 107482–107482. 1 indexed citations
3.
4.
Mohanty, Salini, Nicole Cossrow, Daniel P. Bailey, et al.. (2024). HSD23 Preferences and Attitudes of Healthcare Providers (HCPs) and Adult Healthcare Consumers (HCCs) Towards Pneumococcal Conjugate Vaccines (PCVs) in the United States (US). Value in Health. 27(6). S225–S225. 2 indexed citations
5.
Mohanty, Salini, Nicole Cossrow, Kalvin Yu, et al.. (2024). Clinical and economic burden of invasive pneumococcal disease and noninvasive all-cause pneumonia in hospitalized US adults: A multicenter analysis from 2015 to 2020. International Journal of Infectious Diseases. 143. 107023–107023. 7 indexed citations
6.
Mohanty, Salini, Nicole Cossrow, Meghan White, et al.. (2024). Burden of invasive pneumococcal disease, non-invasive all-cause pneumonia, and acute otitis media in hospitalized US children: a retrospective multi-center study from 2015 to 2020. BMC Health Services Research. 24(1). 1574–1574. 1 indexed citations
7.
8.
Owusu‐Edusei, Kwame, et al.. (2024). Evaluating the health and economic outcomes of a PCV15 vaccination program for adults aged 65 years-and-above in Switzerland. Vaccine. 42(13). 3239–3246. 1 indexed citations
9.
Mohanty, Salini, Gang Ye, Charles Sheets, et al.. (2024). Association Between Social Vulnerability and Streptococcus pneumoniae Antimicrobial Resistance in US Adults. Clinical Infectious Diseases. 79(2). 305–311. 2 indexed citations
10.
Du, Jing, Frank J. Manion, May D. Wang, et al.. (2023). EPH153 A Natural Language Processing Solution for Health Economics and Outcomes Research Systematic Literature Review. Value in Health. 26(6). S192–S192.
11.
12.
Duke, Elizabeth R., Brian D. Williamson, Bhavesh Borate, et al.. (2020). CMV viral load kinetics as surrogate endpoints after allogeneic transplantation. Journal of Clinical Investigation. 131(1). 40 indexed citations
13.
Waskin, Hetty, et al.. (2020). 1161. Effectiveness of Posaconazole in the Treatment of Rare Invasive Fungal Infections: A Systematic Literature Review. Open Forum Infectious Diseases. 7(Supplement_1). S607–S607. 1 indexed citations
14.
Escobar, Gabriel J., Jennifer M. Baker, Patricia Kipnis, et al.. (2017). Prediction of RecurrentClostridium DifficileInfection Using Comprehensive Electronic Medical Records in an Integrated Healthcare Delivery System. Infection Control and Hospital Epidemiology. 38(10). 1196–1203. 35 indexed citations
15.
Prabhu, Vimalanand S., Erik R. Dubberke, Marcus Dörr, et al.. (2017). Cost-effectiveness of Bezlotoxumab Compared With Placebo for the Prevention of Recurrent Clostridium difficile Infection. Clinical Infectious Diseases. 66(3). 355–362. 59 indexed citations
16.
Cossrow, Nicole, Manjiri Pawaskar, Edward A. Witt, et al.. (2016). Estimating the Prevalence of Binge Eating Disorder in a Community Sample From the United States. The Journal of Clinical Psychiatry. 77(8). e968–e974. 88 indexed citations
17.
Falkner, Bonita & Nicole Cossrow. (2014). Prevalence of Metabolic Syndrome and Obesity-Associated Hypertension in the Racial Ethnic Minorities of the United States. Current Hypertension Reports. 16(7). 449–449. 98 indexed citations
18.
Mehra, Maneesha, et al.. (2013). Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims Database. PLoS ONE. 8(10). e76882–e76882. 117 indexed citations
19.
Mehra, Mandeep R., et al.. (2013). Assessment of tuberculosis burden in China using a dynamic disease simulation model. The International Journal of Tuberculosis and Lung Disease. 17(9). 1186–1194. 24 indexed citations
20.
Mehra, Maneesha, et al.. (2012). Use of a Claims Database to Characterize and Estimate the Incidence of Castleman's Disease. Blood. 120(21). 4253–4253. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anupama Kalsekar Breakdown of academic impact, for papers by Denise C. Vidot Breakdown of academic impact, for papers by Gregory Traversy Breakdown of academic impact, for papers by Giovanni Baglìo Breakdown of academic impact, for papers by Sam Kosari Breakdown of academic impact, for papers by Yelena Bird Breakdown of academic impact, for papers by Ai‐Lin Tsai Breakdown of academic impact, for papers by Arlene Hankinson Breakdown of academic impact, for papers by Caleb Bliss Breakdown of academic impact, for papers by Roxane Carr
Rankless by CCL
2026